The Power of RNA Amplified
Impact measured in billions.
YOUR CELLs’ vERY OWN COPY MACHINERY
Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.
OUR SCIENCeENABLING BROAd APPLICATIONs FOR RNA TREATMENTs
Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.
PIPELINeNews & Publications
08.21.24
Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
05.11.24
Press Releases
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
05.11.24
Publications & Presentations
Single and Low Dose Self Replicating RNA Vaccine Provides Effective Immune Protection Against Rabies in Healthy Volunteers